Skip to main content
logo
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.98
-0.03 (-0.37%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Puma Biotechnology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
227.18228.37230.47235.64228.03253.16
Revenue Growth
-2.38%-0.91%-2.19%3.34%-9.92%12.46%
Gross Profit
169.15170.21166.06172.96172.94189.45
Operating Income
29.4937.330.9732.6423.721.29
Net Income
24.3831.1130.2821.590-29.13
Earnings Per Share
0.480.610.620.45--0.72
EPS Growth
-37.66%-1.61%37.78%---

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
101.5597.53100.9795.9481.0782.11
Total Debt
15.9528.5574.08111.49114.28116.64
Net Cash (Debt)
85.5968.9826.88-15.55-33.21-34.54
Net Cash Growth
172.12%156.60%----
Net Cash Per Share
1.681.360.55-0.33-0.74-0.85

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
53.6141.838.9227.01-15.8320.65
Capital Expenditures
-0.01-0.07-0.06-0.14--
Free Cash Flow
53.641.7338.8626.87-15.8320.65
Free Cash Flow Growth
71.96%7.38%44.64%--2740.44%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
74.46%74.53%72.06%73.40%75.84%74.84%
Operating Margin
12.98%16.33%13.44%13.85%10.40%0.51%
Pretax Margin
12.80%15.67%10.46%9.62%0.20%-11.38%
Profit Margin
10.73%13.62%13.14%9.16%0.00%-11.51%
FCF Margin
23.59%18.27%16.86%11.40%-6.94%8.16%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.689.754.929.62--
Forward PE
29.8312.5511.6210.5733.92127.84
P/FCF Ratio
7.587.193.857.68-6.06
PS Ratio
1.791.310.650.880.860.49